Clinical Trial Update: Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the safety and effectiveness of the elbasvir/grazoprevir combination in hemodialysis patients with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Elbasvir/Grazoprevir (Zepatier) (elbasvir/grazoprevir)

Snippet

Sponsor: Norte Study Group | Conditions: Chronic Hepatitis C | Phase 4 | Status: UNKNOWN